Recent News for BHVN - Biohaven Pharmaceutical Holding Company Ltd.

Date Title
May 17 The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering
May 10 Biohaven Pharmaceutical (BHVN) Presents At American Academy of Neurology Annual Meeting - Slideshow
May 8 Biohaven's migraine med rimegepant shows positive effect when dosed on schedule
May 8 Biohaven Announces Expanded Safety And Preliminary Preventive Efficacy Data From Ongoing Long-Term Safety Study, And Presents Case Reports Of Using Rimegepant To Successfully Treat Breakthrough Migraine Attacks In Patients Taking Preventive CGRP-Target...
May 8 Biohaven Advances Late Stage Clinical Programs And Novel Targets From Neuroinnovation Platforms
May 7 The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex
May 7 Biohaven Pharmaceuticals beats by $0.09
May 7 Biohaven Pharmaceuticals Reports First Quarter 2019 Financial Results And Advancements In Neuroinnovation Platforms
May 6 Benzinga's Top Upgrades, Downgrades For May 6, 2019
May 3 The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen
May 3 Biohaven Announces Late-Breaking Oral Presentation Of Rimegepant Zydis® ODT Phase 3 Results At American Academy Of Neurology (AAN) 2019 Annual Meeting And New Data Release At Investor Event
May 2 Hedge Funds Have Never Been This Bullish On Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Apr 27 The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Apr 26 The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug
Apr 26 Analysts point to potential Biogen M&A options after Alzheimer's failure
Apr 17 The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO
Apr 16 The Daily Biotech Pulse: J&J Earnings, FDA Nod For Mediconova, Proteon To Explore Strategic Alternatives
Apr 16 The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives
Apr 15 Implied Volatility Surging for Biohaven Pharmaceutical (BHVN) Stock Options
Apr 12 Here's Why Biohaven Pharmaceutical Jumped 20% Today
Apr 12 CBX: Strong earnings for financials a good start
Apr 12 General Electric, Biohaven Pharmaceutical Holding, Tesla and More Are Trending
Apr 12 Rumor du jour: Biohaven up 14% on takeover interest
Apr 9 Benzinga's Top Upgrades, Downgrades For April 9, 2019
Apr 3 Biohaven expands leadership team

Back to the Main BHVN Page...